VANGUARD GROUP INC - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 19 filers reported holding CLEVELAND BIOLABS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q2 2021$533,000
+49.3%
97,535
+43.2%
0.00%
Q1 2021$357,000
+97.2%
68,092
+29.5%
0.00%
Q4 2020$181,000
+74.0%
52,5920.0%0.00%
Q3 2020$104,000
-23.0%
52,5920.0%0.00%
Q2 2020$135,000
+53.4%
52,5920.0%0.00%
Q1 2020$88,000
+319.0%
52,592
+50.5%
0.00%
Q4 2019$21,000
-61.1%
34,953
-34.2%
0.00%
Q3 2019$54,000
-29.9%
53,085
+0.4%
0.00%
Q2 2019$77,000
-56.2%
52,874
-50.4%
0.00%
Q1 2019$176,000
+63.0%
106,6740.0%0.00%
Q4 2018$108,000
-68.4%
106,674
-37.4%
0.00%
Q3 2018$342,000
-18.4%
170,3470.0%0.00%
Q2 2018$419,000
-18.5%
170,3470.0%0.00%
Q1 2018$514,000
-18.5%
170,347
+8.3%
0.00%
Q4 2017$631,000
+7.7%
157,246
-7.6%
0.00%
Q3 2017$586,000
+17.0%
170,0880.0%0.00%
Q2 2017$501,000
+279.5%
170,088
+106.9%
0.00%
Q1 2017$132,000
+12.8%
82,2030.0%0.00%
Q4 2016$117,000
-18.2%
82,2030.0%0.00%
Q3 2016$143,000
-42.3%
82,203
-6.6%
0.00%
Q2 2016$248,000
+11.2%
88,0180.0%0.00%
Q1 2016$223,000
-27.1%
88,018
+0.6%
0.00%
Q4 2015$306,000
-99.8%
87,518
-98.1%
0.00%
-100.0%
Q3 2015$162,991,000
+45049.9%
4,644,077
+5483.0%
0.01%
Q2 2015$361,000
+22.4%
83,183
+1.4%
0.00%
Q1 2015$295,00082,0480.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q2 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 320,053$1,104,0000.04%
Renaissance Technologies 165,651$571,0000.00%
VANGUARD GROUP INC 52,592$181,0000.00%
UBS Group AG 4,812$17,0000.00%
IFP Advisors, Inc 150$1,0000.00%
OSAIC HOLDINGS, INC. 290$1,0000.00%
BANK OF AMERICA CORP /DE/ 100$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 15,000$52,0000.00%
WELLS FARGO & COMPANY/MN 34$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CLEVELAND BIOLABS INC shareholders